Albert P Parker is Chief Legal Officer of Zynerba Pharmaceuticals, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Zynerba Pharmaceuticals, Inc.
11 Oct 23
4
Zynerba Pharmaceuticals, Inc.
17 Feb 23
4
Zynerba Pharmaceuticals, Inc.
9 Feb 23
4
Zynerba Pharmaceuticals, Inc.
2 Feb 23
4
Zynerba Pharmaceuticals, Inc.
25 Jan 23
4
Zynerba Pharmaceuticals, Inc.
15 Feb 22
3
Zynerba Pharmaceuticals, Inc.
15 Feb 22
4
OncoCyte Corp
15 Dec 20
4
OncoCyte Corp
5 Aug 20
4
Oncocyte Corp
12 Feb 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 278,333 | 0.00 | 0 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 85,000 | 0.00 | 278,333 |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 33,685 | 0.00 | 193,333 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.7 | 200,000 | 540.00 k | 0 |
15 Feb 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 0.5418 | 3,173 | 1.72 k | 227,018 |
8 Feb 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 0.5965 | 5,463 | 3.26 k | 230,191 |
7 Feb 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 18,864 | 0.00 | 235,654 |
1 Feb 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 0.5952 | 5,841 | 3.48 k | 216,790 |
31 Jan 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 17,631 | 0.00 | 222,631 |
24 Jan 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 170,000 | 0.00 | 205,000 |